Skip to content

IVD Under the Limelight at The MedTech Conference 2025: Highlighting our Site's Role

Zach Rothstein, head of Dx's executive team, expounds on the timely significance of this year's diagnostic programming, suggesting it represents a pivotal moment for leaders in the In Vitro Diagnostic (IVD) field. This pivotal moment is a result of regulatory modernization, reimbursement...

InFocus: In-Vitro Diagnostics (IVD) Take Center Stage at The MedTech Conference 2025 on Our...
InFocus: In-Vitro Diagnostics (IVD) Take Center Stage at The MedTech Conference 2025 on Our Platform

IVD Under the Limelight at The MedTech Conference 2025: Highlighting our Site's Role

The MedTech Conference, a global gathering for medical technology leaders, returns to San Diego from October 5-8, 2025. This major international event brings together over 3,500 industry pioneers for around 400 sessions, focusing on innovation, regulation, health economics, policy, and networking within the medtech sector.

The conference serves as a platform for critical discussions on key topics such as regulatory issues, digital health technologies, market access, and collaboration to advance healthcare technology worldwide. The agenda is structured around five themes: Diagnostic Innovation & Scientific Advances, Accelerating Access to Reliable and Accurate Testing, Policy & Regulatory Alignment for Diagnostics, Clinical Integration & Adoption, and Stakeholder Collaboration.

Scott Whitaker, president and CEO of the medtech association, has issued statements on the White House's "America's AI Action Plan" and the Trump administration's "Make America Healthy Again" initiative. Sixty-seven stakeholder groups, including patient advocacy groups, state medtech and life sciences associations, and our website, are urging the Centers for Medicare and Medicaid Services (CMS) to create a timely, streamlined pathway for Medicare patients to access FDA-authorized breakthrough medical technology.

The MedTech Conference offers unparalleled access to C-suite leaders, institutional investors, regulatory officials, payers, and patient advocacy groups. For IVD companies, this event provides an opportunity to connect with key decision-makers and showcase their latest innovations at The Medtech Campus. Major diagnostics companies will be exhibiting their cutting-edge technology at the conference.

The Medtech Campus, the conference's central hub, offers diagnostics executives an efficient platform for relationship building, brand positioning, and technology exploration. The Patient Advocacy Pavilion provides critical perspective on the human impact of diagnostics, while the our websiteDx Town Hall establishes priorities for the next phase of the organisation's work.

Shaye Mandle, Executive Director of our website's Digital Health Tech Division, and DeChane Dorsey, Executive Director of our website Accel, will be discussing the policy and tech trends making this a breakthrough moment for digital health and the significance of this year's programming for small companies and entrepreneurs, respectively.

Christopher L. White, Esq., the General Counsel & Chief Policy Officer of our website, emphasises the importance of legal, compliance, and regulatory programming at The MedTech Conference 2025. Our websiteDx has curated a program that reflects the priorities of diagnostics companies and the broader IVD community, bringing together policymakers, patient advocates, and industry leaders to tackle the issues that matter most.

If you're committed to having a voice in the decisions that will define diagnostics for the coming years, attending The MedTech Conference is essential. The 2025 agenda for The MedTech Conference focuses on the intersection of innovation, policy, and patient access. Don't miss out on this opportunity to be part of the conversation shaping the future of medical technology.

Read also: